TrialMolecular imaging and biology2017

Initial Experience with Tositumomab and I-131-Labeled Tositumomab for Treatment of Relapsed/Refractory Hodgkin Lymphoma.

Heather Jacene et al.PubMed ↗Publisher ↗

No numbers read from the abstract.